2016 New Hampshire Revised Statutes
Title X - PUBLIC HEALTH
Chapter 126-Z - TERMINAL PATIENTS' RIGHT TO TRY ACT
Section 126-Z:2 - Availability of Investigational Drugs, Biological Products, or Devices; Costs; Coverage.

NH Rev Stat § 126-Z:2 (2016) What's This?
    126-Z:2 Availability of Investigational Drugs, Biological Products, or Devices; Costs; Coverage. –
    I. A manufacturer of an investigational drug, biological product, or device may make available an investigational drug, biological product, or device to eligible patients pursuant to this chapter. A manufacturer may:
       (a) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.
       (b) Require an eligible patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device.
       (c) Require an eligible patient to participate in data collection relating to the use of the investigational drug, biological product, or device.
    II. This chapter shall not require a health care insurer or any state agency to provide coverage for the cost of any investigational drug, biological product, or device.
    III. Nothing in this chapter shall require the manufacturer of an investigational drug, biological product, or device to include an eligible patient in a particular clinical trial or study.

Source. 2016, 206:2, eff. June 6, 2016.

Disclaimer: These codes may not be the most recent version. New Hampshire may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.